1,2-Benzisoxazole-3-acetamide derivatives as dual agents for DPP-IV inhibition and anticancer activity

References

• Drucker, D. J.; Nauck, M. A. The Incretin System: Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes. Lancet 2006, 368, 1696–1705. DOI:10.1016/S0140-6736(06)69705-5
   PubMed Web of Science ®Google Scholar
• Kshirsagar, A. K.; Aggarwal, A. S.; Harle, U. N.; Deshpande, A. V. DPP IV Inhibitors: Successes, Failures and Future Prospects. Diabetes Metab. Syndr. 2011, 5, 105–112. DOI:10.1016/j.dsx.2012.02.017
   PubMedGoogle Scholar
• Abbott, C. A.; McCaughan, G. W.; Baker, E.; Sutherland, G. R. Genomic Organization, Exact Localization, and Tissue Expression of the Human CD26 (Dipeptidyl Peptidase IV) Gene. Immunogenetics 1994, 40, 331–338. DOI:10.1007/BF01246674
   PubMed Web of Science ®Google Scholar
• Cheng, H. C.; Abdel-Ghany, M.; Elble, R. C.; Pauli, B. U. Lung Endothelial Dipeptidyl Peptidase IV Promotes Adhesion and Metastasis of Rat Breast Cancer Cells via Tumor Cell Surface-Associated Fibronectin. J. Biol. Chem. 1998, 273, 24207–24215. DOI:10.1074/jbc.273.37.24207
   PubMed Web of Science ®Google Scholar
• Wesley, U. V.; Albino, A. P.; Tiwari, S.; Houghton, A. N. A Role for Dipeptidyl Peptidase IV in Suppressing the Malignant Phenotype of Melanocytic Cells. J. Exp. Med. 1999, 190, 311–322. DOI:10.1084/jem.190.3.311
   PubMed Web of Science ®Google Scholar
• Pethiyagoda, C. L.; Welch, D. R.; Fleming, T. P. Dipeptidyl Peptidase IV (DPPIV) Inhibits Cellular Invasion of Melanoma Cells. Clin. Exp. Metastasis. 2000, 18, 391–400. DOI:10.1023/A:1010930918055
   PubMed Web of Science ®Google Scholar
• Aytac, U.; Clart, F. X.; Ho, L.; Sato, K.; Ohnuma, K.; Mills, G. B.; Cabanillas, F.; Morimoto, C.; Dang, N. H. Expression of CD26 and Its Associated Dipeptidyl Peptidase IV Enzyme Activity Enhances Sensi-Tivity to Doxorubicin-Induced Cell Cycle Arrest at the G(2)/M Checkpoint. Cancer Res. 2001, 61, 7204–7210.
   PubMed Web of Science ®Google Scholar
• (a) Villhauer, E. B.; Brinkman, J. A.; Naderi, G. B.; Burkey, B. F.; Dunning, B. E.; Prasad, K.; Mangold, B. L.; Russell, M. E.; Hughes, T. E. 1-[[(3-Hydroxy-1-Adamantyl)Amino]Acetyl]-2-Cyano-(S)-Pyrrolidine: A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic Properties. J. Med. Chem. 2003, 46, 2774–2789. (b) Kim, D.; Wang, L.; Beconi, M.; Eiermann, G. J.; Fisher, M. H.; He, H.; Hickey, G. J.; Kowalchick, J. E.; Leiting, B.; Lyons, K.; et al. (2R)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-Dihydro[1,2,4]Triazolo[4,3-a]Pyrazin-7(8H)-Yl]-1-(2,4,5-Trifluorophenyl)Butan-2-Amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes. J. Med. Chem. 2005, 48, 141–151.
   PubMed Web of Science ®Google Scholar
• Biftu, T.; Sinha-Roy, R.; Chen, P.; Qian, X.; Feng, D.; Kuethe, J. T.; Scapin, G.; Gao, Y. D.; Yan, Y.; Krueger, A.; et al. Omarigliptin (MK-3102): A Novel Long-Acting DPP-4 Inhibitor for Once-Weekly Treatment of Type 2 Diabetes. J. Med. Chem. 2014, 57, 3205–3212.
   PubMed Web of Science ®Google Scholar
• Hansen, J.; Deacon, C. F.; Orskov, C.; Holst, J. J. Glucagon-like Peptide-1-(7–36)Amide is Transformed to Glucagon-like Peptide-1-(9–36)Amide by Dipeptidyl Peptidase IV in the Capillaries Supplying the L Cells of the Porcine Intestine. Endocrinology 1999, 140, 5356–5363.
   PubMed Web of Science ®Google Scholar
• (a) Dang, N. H.; Morimoto, C. CD26: An Expanding Role in Immune Regulation and Cancer. Histol. Histopathol. 2002, 1. 1213–1226. (b) Iwata, S.; Morimoto, C. CD26/Dipeptidyl Peptidase IV in Context. The Different Roles of a Multifunctional Ectoenzyme in Malignant Transformation. J. Exp. Med 1999, 190, 301–306.
   Google Scholar
• Liotta, L. A.; Kohn, E. C. The Microenvironment of the Tumour-Host Interface. Nature 2001, 411, 375–379.
   PubMed Web of Science ®Google Scholar
• Bušek, P.; Malik, R.; Šedo, A. Dipeptidyl Peptidase IV Activity and/or Structure Homologues (DASH) and Their Substrates in Cancer. Int. J. Biochem. Cell Biol. 2004, 36, 408–421.
   PubMed Web of Science ®Google Scholar
• Deng, B. L.; Zhao, Y.; Hartman, T. L.; Watson, K.; Buckheit, R. W.Jr; , Pannecouque, C.; Clercq, E. D.; Cushman, M. Synthesis of Alkenyldiarylmethanes (ADAMs) Containing Benzo[d]Isoxazole and Oxazolidin-2-One Rings, a New Series of Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors. Eur. J. Med. Chem. 2009, 44, 1210–1214.
   PubMed Web of Science ®Google Scholar
• Lamani, R. S.; Shetty, N. S.; Kamble, R. R.; Khazi, I. A. M. Synthesis and Antimicrobial Studies of Novel Methylene Bridged Benzisoxazolyl Imidazo[2,1-b][1,3,4]Thiadiazole Derivatives. Eur. J. Med. Chem. 2009, 44, 2828–2833.
   PubMed Web of Science ®Google Scholar
• (a) Aiello, S.; Wells, G.; Stone, E. L.; Kadri, H.; Bazzi, R.; Bell, D. R.; Stevens, M. F. G.; Matthews, C. S.; Bradshaw, T. D.; Westwel, A. D. Synthesis and Biological Properties of Benzothiazole, Benzoxazole, and Chromen-4-One Analogues of the Potent Antitumor Agent 2-(3,4-Dimethoxyphenyl)-5-Fluorobenzothiazole (PMX 610, NSC 721648). J. Med. Chem. 2008, 51, 5135–5139.
   PubMed Web of Science ®Google Scholar
  (b) Arakawa, K.; Inamasu, M.; Matsumoto, M.; Okumura, K.; Yasuda, K. Novel Benzoxazole-2,4-Thiazolidinediones as Potent Hypoglycemic Agents. Synthesis and Structure-Activity Relationships. Chem. Pharm. Bull. 1997, 45, 1984–1993.
   PubMed Web of Science ®Google Scholar
• Sharath Chandra, S. P.; Vishwaprakash Mahadimane, P. Effect of Novel Benzisoxazole Derivatives against Ehrlich Ascites Carcinoma Cells in Swiss Albino Mice: Cytotoxic and Haematological Studies. Int. J. Pharma Sci. Res. 2015, 6, 3606–3611.
   Web of Science ®Google Scholar
• Rajashekar, R. C. B.; Reddy, R.; Revathy, S. T.; Krish, S.; Sabiah, S. Res. J. Pharm. Biol. Chem. Sci. 2014, 5, 873–880.
   Google Scholar
• Shi, G. Q.; Dropinski, J. F.; McKeever, B. M.; Xu, S.; Becker, J. W.; Berger, J. P.; MacNaul, K. L.; Elbrecht, A.; Zhou, G.; Doebber, T. W.; et al. Design and Synthesis of α-Aryloxyphenylacetic Acid Derivatives: A Novel Class of PPARα/γ Dual Agonists with Potent Antihyperglycemic and Lipid Modulating Activity. J. Med. Chem. 2005, 48, 4457–4468.
   PubMed Web of Science ®Google Scholar
• Benaka Prasad, S. B.; Vinaya, K.; Ananda Kumar, C. S.; Swarup, S.; Rangappa, K. S. Synthesis of Novel 6-Fluoro-3-(4-Piperidinyl)-1,2-Benzisoxazole Derivatives as Antiproliferative Agents: A Structure–Activity Relationship Study. Invest. New Drugs 2009, 27, 534–542.
   PubMed Web of Science ®Google Scholar
• Ashwini, N.; Garg, M.; Mohan, C. D.; Fuchs, J. F.; Rangappa, S.; Anusha, S.; Swaroop, T. R.; Rakesh, K. S.; Kanojia, D.; Madan, V.; et al. Synthesis of 1,2-Benzisoxazole Tethered 1,2,3-Triazoles That Exhibit Anticancer Activity in Acute Myeloid Leukemia Cell Lines by Inhibiting Histone Deacetylases, and Inducing p21 and Tubulin Acetylation. Bioorg. Med. Chem. 2015, 23, 6157–6165.
   PubMed Web of Science ®Google Scholar
• (a) Soni, R.; Durgapal, S.; Soman, S. S.; Georrge, J. J. Design, Synthesis and anti-Diabetic Activity of Chromen-2-One Derivatives. Arabian J. Chem. 2016, DOI:10.1016/j.arabjc.2016.11.01. (b) Sharma, R.; Soman, S. S. Design and Synthesis of Sulfonamide Derivatives of Pyrrolidine and Piperidine as anti-Diabetic Agents. Eur. J. Med. Chem. 2015, 90, 342–350.
   Google Scholar
• Patel, J. M.; Soman, S. S. Studies on the Synthesis of Furobenzisoxazole Derivatives. Chem. Heterocycl. Comp. 2009, 45, 1081–1088.
   Web of Science ®Google Scholar
• Soman, S. S.; Soni, J.; Patel, T. Synthesis of New Naphthoisoxazole Amide Derivatives and Study of Their Biological Evaluations. Med. Chem. Res. 2014, 23, 3803–3809.
   Web of Science ®Google Scholar
• Boyd, J.; Robertson, A. The Chemistry of the “Insoluble Red” Woods. Part II. A New Synthesis of 4-Hydroxycoumarins. J. Chem. Soc. 1948, 0, 174–176.
   Web of Science ®Google Scholar
• Posner, I.; Hess, R. Unsaturated Compounds. X. Action of Free Hydroxylamine on Coumarins. Ber. Dtsch. Chem. Ges. 1913, 46, 3816–3833.
   Google Scholar
• (a) Almansa, R.; Guijarro, D.; Meyers, A. Enantioselective Addition of Dialkylzinc Reagents to N-(Diphenylphosphinoyl)Imines Catalyzed by β-Aminoalcohols with the Prolinol Skeleton. Tetrahedron Asymmetry 2007, 18, 2828–2840. (b) Tang, F. Y.; Qu, L. Q.; Xu, Y.; Ma, R. J.; Chen, S. H.; Li, G. Practical Synthesis of Structurally Important Spirodiamine Templates. Synt. Commun. 2007, 37, 3793–3799.
   Google Scholar